284 related articles for article (PubMed ID: 28705600)
1. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
[TBL] [Abstract][Full Text] [Related]
2. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
[TBL] [Abstract][Full Text] [Related]
3. Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study.
Schoeler T; Petros N; Di Forti M; Pingault JB; Klamerus E; Foglia E; Small A; Murray R; Bhattacharyya S
JAMA Psychiatry; 2016 Nov; 73(11):1173-1179. PubMed ID: 27680429
[TBL] [Abstract][Full Text] [Related]
4. Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study.
Patel R; Wilson R; Jackson R; Ball M; Shetty H; Broadbent M; Stewart R; McGuire P; Bhattacharyya S
BMJ Open; 2016 Mar; 6(3):e009888. PubMed ID: 26940105
[TBL] [Abstract][Full Text] [Related]
5. Stressful life events and relapse of psychosis: analysis of causal association in a 2-year prospective observational cohort of individuals with first-episode psychosis in the UK.
Bhattacharyya S; Schoeler T; Di Forti M; Murray R; Cullen AE; Colizzi M
Lancet Psychiatry; 2023 Jun; 10(6):414-425. PubMed ID: 37146625
[TBL] [Abstract][Full Text] [Related]
6. Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study.
Barbeito S; Vega P; Ruiz de Azúa S; Saenz M; Martinez-Cengotitabengoa M; González-Ortega I; Bermudez C; Hernanz M; Corres BF; González-Pinto A
BMC Psychiatry; 2013 Dec; 13():326. PubMed ID: 24289797
[TBL] [Abstract][Full Text] [Related]
7. Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Psychiatry Res; 2017 Sep; 255():36-41. PubMed ID: 28521146
[TBL] [Abstract][Full Text] [Related]
8. Substance use, medication adherence and outcome one year following a first episode of psychosis.
Colizzi M; Carra E; Fraietta S; Lally J; Quattrone D; Bonaccorso S; Mondelli V; Ajnakina O; Dazzan P; Trotta A; Sideli L; Kolliakou A; Gaughran F; Khondoker M; David AS; Murray RM; MacCabe JH; Di Forti M
Schizophr Res; 2016 Feb; 170(2-3):311-7. PubMed ID: 26718334
[TBL] [Abstract][Full Text] [Related]
9. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
Clausen L; Hjorthøj CR; Thorup A; Jeppesen P; Petersen L; Bertelsen M; Nordentoft M
Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
[TBL] [Abstract][Full Text] [Related]
10. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
[TBL] [Abstract][Full Text] [Related]
11. Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.
Schoeler T; Monk A; Sami MB; Klamerus E; Foglia E; Brown R; Camuri G; Altamura AC; Murray R; Bhattacharyya S
Lancet Psychiatry; 2016 Mar; 3(3):215-25. PubMed ID: 26777297
[TBL] [Abstract][Full Text] [Related]
12. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
Hides L; Dawe S; Kavanagh DJ; Young RM
Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
[TBL] [Abstract][Full Text] [Related]
13. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
Reid S; Bhattacharyya S
Psychiatry Res; 2019 Oct; 280():112523. PubMed ID: 31450032
[TBL] [Abstract][Full Text] [Related]
16. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial.
Priebe S; Bremner SA; Lauber C; Henderson C; Burns T
Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868
[TBL] [Abstract][Full Text] [Related]
17. Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP).
Pelayo-Terán JM; Gajardo Galán VG; de la Ortiz-García de la Foz V; Martínez-García O; Tabarés-Seisdedos R; Crespo-Facorro B; Ayesa-Arriola R
Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):315-323. PubMed ID: 27796500
[TBL] [Abstract][Full Text] [Related]
18. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.
Ramdour S; Duxbury JA; Becket G; Wilson S
J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):491-501. PubMed ID: 25990303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
